Association of tumor genomic factors and efficacy for metastasis-directed stereotactic body radiotherapy for oligometastatic colorectal cancerKrishan R. Jethwa, Christopher L. Hallemeier, Samuel Jang et al.|Radiotherapy and Oncology|2020Cited by 37
Comprehensive assessment of circulating immune cell populations in response to stereotactic body radiation therapy in patients with liver cancerMichael P. Gustafson, Christopher L. Hallemeier, Svetlana Bornschlegl et al.|Advances in Radiation Oncology|2017Cited by 34
Long-term Clinical Outcomes and Safety Profile of SBRT for Centrally Located NSCLCAndrea Arnett, Kenneth W. Merrell, Sean S. Park et al.|Advances in Radiation Oncology|2019Cited by 32
Stereotactic Body Radiotherapy for Medically Inoperable Stage I-II Non–Small Cell Lung Cancer: The Mayo Clinic ExperienceC. Hobbs, Robert C. Miller, Stephen Ko et al.|Mayo Clinic Proceedings Innovations Quality & Outcomes|2017Cited by 29
Establishment of practice standards in nomenclature and prescription to enable construction of software and databases for knowledge-based practice reviewCharles S. Mayo, Michael G. Haddock, Thomas M. Pisansky et al.|Practical Radiation Oncology|2016Cited by 27